Niklas Klümper (@niklas_kluemper) 's Twitter Profile
Niklas Klümper

@niklas_kluemper

Uro-Oncologist, Interested in precision oncology. Focus on UC and RCC 🎯 Clinician Scientist and PI @IEO_HolzelLab @UniklinikBonn Tweets are my own

ID: 937630368

linkhttp://ieo.uni-bonn.de/niklas-kluemper/ calendar_today09-11-2012 19:52:10

1,1K Tweet

1,1K Takipçi

3,3K Takip Edilen

Niklas Klümper (@niklas_kluemper) 's Twitter Profile Photo
Niklas Klümper
@niklas_kluemper

6 months ago

What a start at #EAU24 - OS Update of CheckMate274 Adjuvant Nivolumab demonstrates OS benefit for high-risk MIBC, especially in PD-L1+ population! (HR 0.56) Matt Galsky But: Why did adjuvant Nivo perform better than Pembro (AMBASSADOR did not demonstrate OS benefit ASCO

What a start at #EAU24 - OS Update of CheckMate274 Adjuvant Nivolumab demonstrates OS benefit for high-risk MIBC, especially in PD-L1+ population! (HR 0.56) <a href="/MattGalsky/">Matt Galsky</a> But: Why did adjuvant Nivo perform better than Pembro (AMBASSADOR did not demonstrate OS benefit <a href="/ASCO/">ASCO</a>